三腔胃肠管及瑞能在食管贲门癌术后早期肠内营养中的应用

Application of early enteral nutrition with "Freka Trelumina" and "Supportan" after esophageal and cardiac carcinoma operation

目的:探讨三腔胃肠管(Freka Trelum ina)及瑞能(Supportan)在食管贲门癌术后早期肠内营养(EEN)中应用的可行性和安全性。方法:在25例食管癌、5例贲门癌根治术中放置三腔胃肠管,摸索操作经验;术后48h开始以瑞能为主的EN,观察病人反应,在第8天作肝、肾功能检查。结果:所有病人均治愈出院,未发现严重不良反应。结论:采用三腔胃肠管及瑞能进行食管贲门癌切除术后EEN是安全可行的。

Objectives ： To explore the feasibility and safety of EEN with Freka Trelumina and Supportan after esophageal and cardiac carcinoma operation. Methods： 30 patients with esophageal and cardiac carcinoma were retained Freka Trelumina in to jejunum during the operation. All patients were given EEN with Supportan on the 3rd day after the operation. The complication and resumption of digestive tract functions were observed and recorded carefully . Renal and Liver functions were examined on the 8^th day after operation. Results ： od of study. There was no EEN with Freka Trelumina No mortality evidence of and serious complication occurred in all patients during the peridamage of EEN to the renal and liver function. Conclusion： and Supportan after esophageal and cardiac carcinoma is feasible and safe.